Chronic Arterial Occlusion
chronic arterial occlusion is
surgery or endovascular treatment. However, there's no choice but drug treatment for patients for whom these invasive treatments aren't indicated. Currently, there's no drug with proven efficacy for the treatment of CLI. Cilostazol and naftidrofuryl (not marketed in Japan) are demonstrated to be effective within the treatment of IC in several large-scale clinical studies. Cilostazol is suggested because the first-line drug for the treatment of IC. Cilostazol has been reported to enhance claudication distance by approximately 50%, but there's no evidence to support the effectiveness of cilostazol in preventing the progression from IC to CLI. Given these circumstances, there's an urgent got to develop simpler techniques for the treatment of chronic arterial occlusion.Most cases of arterial thrombosis are caused when an artery is broken by atherosclerosis. Fatty deposits build abreast of the walls of the arteries and cause them to harden and narrow. the danger factors for a grume in an artery include: eating a high-fat diet.Examples of medications wont to treat peripheral artery disease include antiplatelet or anticlotting agents, cholesterol-lowering
drugs like statins, medications that increase blood supply to the extremities like cilostazol (Pletal) and pentoxifylline (Trental), and medications that control high vital sign.
High Impact List of Articles
-
Wunderlich syndrome: spontaneous atraumatic rupture of the kidney
Nalaka Gunawansa*, Dinesha Sudusinghe, Dilushi Wijayaratne and Chathurika Beligaswatta
Research Article: Clinical Practice
-
Wunderlich syndrome: spontaneous atraumatic rupture of the kidney
Nalaka Gunawansa*, Dinesha Sudusinghe, Dilushi Wijayaratne and Chathurika Beligaswatta
Research Article: Clinical Practice
-
The CROSS trial: end of the debate on neoadjuvant therapy for esophageal cancer?
JM Pepek, CG Willett and BG Czito
Editorial: Clinical Practice
-
The CROSS trial: end of the debate on neoadjuvant therapy for esophageal cancer?
JM Pepek, CG Willett and BG Czito
Editorial: Clinical Practice
-
Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
Gregory E Holt, Eckhard R Podack and Luis E Raez
Review Article: Clinical Practice
-
Immunotherapy as a strategy for the treatment of non-small-cell lung cancer
Gregory E Holt, Eckhard R Podack and Luis E Raez
Review Article: Clinical Practice
-
Importance of integrated care for the chronic obstructive pulmonary disease patient
Emiel FM Wouters, and Ingrid ML
Perspective: Clinical Practice
-
Importance of integrated care for the chronic obstructive pulmonary disease patient
Emiel FM Wouters, and Ingrid ML
Perspective: Clinical Practice
-
Indirect and direct anticoagulants predominantly inhibiting factor Xa
Job Harenberg
Review Article: Clinical Practice
-
Indirect and direct anticoagulants predominantly inhibiting factor Xa
Job Harenberg
Review Article: Clinical Practice
Relevant Topics in Clinical